Your browser doesn't support javascript.
loading
ZEB1 and oncogenic Ras constitute a regulatory switch for stimulus-dependent E-cadherin downregulation.
Otake, Shigeo; Itoh, Yuka; Omata, Chiho; Saitoh, Masao; Miyazawa, Keiji.
Afiliação
  • Otake S; Department of Biochemistry, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
  • Itoh Y; Department of Biochemistry, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
  • Omata C; Department of Biochemistry, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
  • Saitoh M; Department of Biochemistry, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
  • Miyazawa K; Center for Medical Education and Science, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
Cancer Sci ; 112(1): 205-216, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33068045
E-cadherin, an epithelial cell-specific cell adhesion molecule, has both promoting and suppressing effects on tumor invasion and metastasis. It is often downregulated during cancer progression through gene deletion/mutation, transcriptional repression, or epigenetic silencing. We describe a novel regulatory switch to induce stimulus-dependent downregulation of mRNA encoding E-cadherin (CDH1 mRNA) in KRAS-mutated cancer cells. The regulatory switch consists of ZEB1 and oncogenic K-Ras, does not target the promoter region of CDH1, and requires an external cue to temporally downregulate E-cadherin expression. Its repressive effect is maintained as long as the external stimulus continues and is attenuated with cessation of the stimulus. Contextual external cues that turn this regulatory switch on include activation of protein kinase C or fibroblast growth factor signaling. The mode of action is distinct from that of EPCAM repression by ZEB1, which does not require an external cue. Thus, KRAS-mutated cancer cells acquire a novel mode of regulating E-cadherin expression depending on ZEB1, which could contribute to phenotypic plasticity of cancer cells during malignant progression.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Antígenos CD / Caderinas / Regulação para Baixo / Proteínas Proto-Oncogênicas p21(ras) / Homeobox 1 de Ligação a E-box em Dedo de Zinco Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Antígenos CD / Caderinas / Regulação para Baixo / Proteínas Proto-Oncogênicas p21(ras) / Homeobox 1 de Ligação a E-box em Dedo de Zinco Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão